RecallRadar

FDA Device recall Z-2329-2016

6F/7F MynxGrip Vascular Closure Device

On 2016-08-10 the FDA classified a Class II recall of 6F/7F MynxGrip Vascular Closure Device by Accessclosure A Cardinal Health, citing A total of 70 6F/7F Mynx Grip devices were shipped from a distributor using improper transport/packaging configurations.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2329-2016
ClassificationClass II
Statusterminated
Initiated2016-07-13
Published2016-08-10
Last updated2026-09-13 11:54 UTC
CompanyAccessclosure A Cardinal Health
DistributionCA, MS

Product

6F/7F MynxGrip Vascular Closure Device; Product Model MX6721, Product Usage: The 6F/7F MynxGrip Vascular Closure Device is indicated for use to seal femoral arterial and femoral venous access sites while reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures utilizing a 6F or 7F procedural sheath. The 6F/7F MynxGrip Vascular Closure Device is designed to achieve femoral artery and femoral vein hemostasis via delivery of an extravascular, water-soluble synthetic sealant using a balloon catheter in conjunction with a standard procedural sheath. The sealant is comprised of a polyethylene glycol (PEG) material which expands upon contact with subcutaneous fluids to seal the arteriotomy or venotomy. The sealant is resorbed by the body within 30-days.

Reason

A total of 70 6F/7F Mynx Grip devices were shipped from a distributor using improper transport/packaging configurations.

Identifiers

code_infoLot No: F1609702, Expiry 4/20/2018; Lot No. F1534302, Expiry 12/31/2016

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2329-2016%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.